Table 6. Total economic impact of dengue infection 2012–2016, considering 25 endemic states in Mexico and differences between expansion factors.
Year | Applied Factor | Direct Medical Costs to the Healthcare System* (US$ Average use cost) |
Total cost of dengue from the patient’s perspective(direct medical costs + direct nonmedical costs + productivity loss) (US$ Average cost, 95%CI) |
Total Program cost in 25 endemic states* (US$) |
Total economic Impact (US$) |
---|---|---|---|---|---|
2012 | Without factor | $44,087,916 | $4,932,375 ($2,422,817–$9,113,607) |
$95,441,720 | $144,462,012 |
Health Facility | $75,670,378 | $7,143,989 ($3,496,817–$13,135,868) |
$178,256,087 | ||
All SYM | $110,006,382 | $10,238,311 ($5,009,783–$18,817,016) |
$215,686,412 | ||
2013† | Without factor | $53,060,853 | $5,601,279 ($2,748,255–$10,333,288) |
$102,454,898 | $161,117,031 |
Health Facility | $98,082,454 | $8,249,005 ($4,026,495–$15,109,541) |
$208,786,358 | ||
All SYM | $143,369,590 | $11,839,938 ($5,776,587–$21,672,913) |
$257,664,426 | ||
2014† | Without factor | $24,291,393 | $2,575,436 ($1,263,742–$4,751,761) |
$106,742,637 | $133,609,466 |
Health Facility | $44,668,865 | $3,788,038 ($1,849,402–$6,940,494) |
$155,199,540 | ||
All SYM | $65,269,435 | $5,436,411 ($2,652,956–$9,954,349) |
$177,448,483 | ||
2015† | Without factor | $19,253,681 | $1,742,674 ($852,167–$3,199,989) |
$110,432,820 | $131,429,174 |
Health Facility | $41,656,655 | $2,691,312 ($1,303,578–$4,877,179) |
$154,780,787 | ||
All SYM | $55,582,249 | $3,879,108 ($1,877,360–$7,021,673) |
$169,739,325 | ||
2016† | Without factor | $13,223,416 | $1,187,969 ($580,813–$2,180,877) |
$115,794,366 | $130,205,751 |
Health Facility | $24,839,701 | $1,839,121 ($890,462–$3,331,053) |
$146,429,509 | ||
All SYM | $38,502,762 | $2,651,361 ($1,282,654–$4,796,611) |
$156,843,113 |
* PAATY methodology;
†years adjusted by inflation
Health facility: Patients who visited a health facility, expansion factor 3.7 ambulatory and 1.4 hospitalized; All SYM: All symptomatic dengue infections, expansion factor 5.6 ambulatory and 2.0 hospitalized.